News

Beloved Real Housewives of Atlanta star and celebrity hairstylist, Dwight Eubanks, 64, recently revealed to his fans and the public that he was diagnosed with prostate cancer. Although his ...
We read with great interest the published results of the RADIOSA trial by Giulia Marvaso and colleagues.1 This well designed ...
The proposed lung cancer classification uses modified U-Net based lobe segmentation and nodule detection model consisting of three phases. The first phase segments lobe using CT slice and predicted ...
The U.S. Food and Drug Administration (FDA) approved updated labeling for Talzenna (talazoparib) plus Xtandi (enzalutamide) for men with homologous recombination repair (HRR) gene-mutated metastatic ...
We aimed to assess efficacy and safety of cabozantinib, a tyrosine kinase inhibitor with immunomodulatory properties, plus the PD-L1 inhibitor atezolizumab in these patients. CONTACT-02 is an ...
Prostate cancer has a high rate of survival when detected in the early stages. If your family has a history of such cancers, or if you notice certain symptoms, go for a screening.
Cancer of the prostate is a common and serious health concern. According to the American Cancer Society, prostate cancer is the most common form of cancer in men older than age 50, and the third ...
The randomised, open-label, phase 3, non-inferiority PACE-C trial, conducted at 53 hospitals across the UK, Republic of Ireland, and New Zealand, recruited men aged at least 18 years with intermediate ...
In many cases, early-stage prostate cancer will not spread or cause any problems or side effects for a long time, if ever. That’s why your health care provider may suggest active surveillance. This is ...
All biopsies were positive for prostate cancer, and included identification of 2 pelvic lymph nodes, 1 extra-pelvic lymph node, and 1 bone lesion. Overall, 64 Cu-SAR-Bombesin was safe and well ...
The American Cancer Society estimates that more than 313,780 cases of prostate cancer will be diagnosed in the United States in 2025, resulting in approximately 35,770 deaths.
Prostate cancer is now the most common cancer in England, with one in eight men diagnosed in their lifetime, but unlike other major cancers, there is still no national screening programme.